Compare Nuwellis Inc (NUWE) vs Block Inc (XYZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Block Inc — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while Block Inc trades at $77.24 (market cap $45.20B). The key difference: Block Inc is far larger — about 20545.5× Nuwellis Inc's market cap, and Block Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Block Inc for 78 Days on average.
| NUWE | XYZ | |
|---|---|---|
Market Cap | $2.20M | $45.20B |
Volume | 121,544 | 8,386,094 |
Sector | Health | Technology |
52-Week High | $146.65 | $84.85 |
52-Week Low | $0.68 | $49.04 |
Typical Hold Time | 26 Days | 78 Days |
Enterprise Value | -$1.52M | $40.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
XYZ trades at $75.21, down 1.13% on the day, with a bearish technical signal but strong analyst support. The company reported mixed earnings, beating in Q1 and Q2 2026 but missing in Q4 2025, with Q3 results pending. Revenue growth has been steady, reaching $24.19B in 2025, though net income margin compressed to 1.43%. Cash flow trends show volatility, with 2025 net cash flow negative $749.24M due to heavy investing activity.
The stock offers potential upside to the consensus price target of $97.47, supported by a 76.9% buy rating from analysts. However, risks include high P/E of 134.34, margin pressures, and insider selling. Positive developments include expanding partnerships and a potential federal trust bank application, which could enhance profitability long-term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →
